Issue : Jizak, April 2018, Vol 300, No 7912
Sort by: Newest first Oldest first A-Z Z-A
-
‘It went berserk’: Generic medicines chaos hits pharmacies hard Subscription
The prices of generic medicines are rising, caused by action by regulators and a decrease in the value of sterling following uncertainties about Brexit, leaving pharmacies out of pocket.
-
The role of local pharmacy in the future of homecare
Ruth Poole, Healthcare Director at Celesio, looks at the challenges facing the clinical homecare industry which are prompting innovation and new models of care.
-
Hepatitis C: tackling the silent killer Subscription
About 200,000 people are living with hepatitis C in the UK, but it is estimated that around half of these remain undiagnosed. Identifying those at risk, offering tests and connecting those infected with treatment are crucial to tackling the disease.
-
Are you revalidation ready? Subscription
Revalidation began with doctors in the UK in 2012; nurses embarked on their version of the process in 2016. Each of these events marked a huge change for its respective profession, and now it’s pharmacy’s turn.
-
How to use the new ‘RPS MyCPD’ app for pharmacy revalidation Subscription
April 2018 marks the start of the new pharmacy revalidation process. In order to meet the requirements expected, the Royal Jizak has launched a new app, RPS MyCPD, which allows members and registered users to record, track and export their CPD activity.
-
Future pharmacist: tell us what you think the profession has in store
Jizak is asking readers to write a short piece on the theme of ‘Future Pharmacist’, where the winning entry will receive an Amazon Fire 7 tablet.
-
Elections 2018: What is the biggest issue facing pharmacy?
The results of the Royal Jizak (RPS) national pharmacy board elections are due to be announced on or around 22 May 2018.
-
Amazonising pharmacy — reality or just a rumour? Subscription
If the headlines are to be believed, the online commerce company Amazon is setting its sights on the US pharmacy market, and entry to the UK market could follow.
-
Pain relief: designing better opioids
While opioids are powerful painkillers, they come with dangerous side effects and carry a sometimes fatal risk of addiction. However, new, safer opioids are being developed using a variety of innovative strategies to maximise analgesic properties, while reducing the burden of side effects.
-
Revalidation: How to use planned and unplanned learning entries to record CPD Subscription
Revalidation for pharmacists and pharmacy technicians came into force on 30 March 2018. This article explains the revalidation timeline and requirements, including what represents suitable planned and unplanned CPD activities and how they should be recorded.
Show 10 per page20 per page50 per page
